BioWorld

May 16, 2000

View Archived Issues

Vaccinia Virus Vector, Loaded With Prostate-Specific Antigen, In Phase II Cancer Vaccine Trial

Read More

Other News To Note

Read More

Appointments and Advancements

Read More

European Patent Disclosures

Read More

Allergan Enters $30M Deal With UK Center's Neurotoxin Program

Read More

Amgen, TKT Offer Opening Statements In Patent Battle

Read More